Emkay Global's Dr. Satish Ugrankar exits board after completing second term
Emkay Global Financial Services announced that Dr. Satish Ugrankar has stepped down as an Independent Director effective August 9, 2026, upon completing his maximum permissible second term. He vacates all committee memberships, including Chairperson of the Stakeholder's Relationship Committee.

*this image is generated using AI for illustrative purposes only.
Emkay Global Financial Services announced that Dr. Satish Ugrankar has ceased to be a member of its Board of Directors effective August 9, 2026. The departure marks the conclusion of his second consecutive five-year tenure as an Independent Director, a limit imposed by regulatory guidelines to ensure board refreshment. This change affects the composition of several key board committees, requiring the company to appoint replacements to maintain compliance with SEBI listing regulations.
The exit was disclosed pursuant to Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dr. Ugrankar’s DIN is 00043783. The Board of Directors expressed appreciation for his contributions during his tenure. In line with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, the company provided detailed disclosures regarding the change in directorship.
Committee Exits
Upon ceasing to be a director, Dr. Ugrankar automatically vacated his positions in all board committees. His roles included:
- Chairperson of the Stakeholder's Relationship Committee
- Member of the Audit Committee
- Member of the Nomination, Remuneration and Compensation Committee
These vacancies must be filled by the Board to ensure continuous oversight in these critical governance areas.
What This Means for Governance
The completion of a second term for an Independent Director is a standard procedural event under Indian corporate law, designed to prevent entrenchment and bring fresh perspectives to the board. For investors, this signals a routine governance update rather than a strategic shift or conflict. The primary implication is the administrative task of identifying and appointing a new Independent Director who meets the eligibility criteria set by SEBI. Until a successor is appointed, the remaining Independent Directors will manage the committee responsibilities, though companies typically move quickly to fill such gaps to avoid any perception of non-compliance with quorum requirements for committee meetings.
Historical Stock Returns for Emkay Global Financial Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.79% | +5.39% | +7.33% | +17.15% | +21.84% | 0.0% |
What specific qualifications or industry expertise is Emkay Global prioritizing when searching for Dr. Ugrankar's successor to the Board?
How might the transition of the Stakeholder's Relationship Committee chairmanship impact the company's investor communication strategy in the short term?
Are there any pending regulatory filings or audit cycles that could be affected by the temporary vacancy in the Audit Committee before a new member is appointed?


































